Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3231 | Placebo Oral Tablet Wiki | 1.00 |
drug506 | BI 764198 - Formula D Wiki | 1.00 |
drug1763 | Gabapentin Enacarbil Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D012148 | Restless Legs Syndrome NIH | 1.00 |
D000544 | Alzheimer Disease NIH | 0.32 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0012452 | Restless legs HPO | 1.00 |
HP:0002511 | Alzheimer disease HPO | 0.32 |
Navigate: Correlations HPO
There is one clinical trial.
BI 764198 is intended to be used in patients hospitalized for COVID-19 at risk of respiratory complications. The present trial will investigate the relative bioavailability of BI 764198 administered as capsules versus tablets in a first part, and the relative bioavailability and food effect of four oral formulations: the newly developed tablet formulation under fed and fasted conditions as well as suspension from capsules and suspension from tablets in a second part.
Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports